Leadership Overview
Arthrex has 6 executives leading key functions including finance, operations, and sales.
Driven by innovation, Arthrex provides advanced orthopedic products and medical education, empowering surgeons globally to improve patient outcomes and advance the field of orthopedics.
Driven by innovation, Arthrex provides advanced orthopedic products and medical education, empowering surgeons globally to improve patient outcomes and advance the field of orthopedics.
Leadership Roles at Arthrex
Marie Stewart - Chief Financial Officer
Marie Stewart, the Chief Financial Officer at Arthrex, directs all financial operations and strategic fiscal planning. Stewart oversees budgeting, forecasting, and financial reporting, ensuring robust financial health and compliance across the organization. This leadership role involves managing investment strategies and optimizing capital allocation to support Arthrex's growth initiatives in medical device innovation and global expansion. Stewart's financial acumen is critical for maintaining profitability and driving sustainable economic performance. By meticulously analyzing market trends and financial data, the Chief Financial Officer ensures that Arthrex's financial strategies align with its long-term objectives. Marie Stewart's oversight extends to risk management, safeguarding the company's assets and ensuring fiscal integrity in all business dealings.
Matthew Hilgefort - Chief Operating Officer
Matthew Hilgefort, the Chief Operating Officer at Arthrex, orchestrates the company's global operational efficiency and supply chain management. Hilgefort directs manufacturing processes, logistics, and operational scaling to meet the increasing demand for Arthrex's orthopedic products. This executive leadership position involves ensuring seamless integration between product development, production, and distribution channels, thereby enhancing overall business performance. Matthew Hilgefort's focus is on optimizing resource utilization and implementing best practices to maintain high standards of quality and delivery. By driving operational excellence, the Chief Operating Officer supports Arthrex's mission to provide surgeons with innovative solutions. Hilgefort's strategic oversight ensures that the company's operational infrastructure effectively supports its market presence and commitment to customer satisfaction.
Curt Reekers - Agency Owner and President
Curt Reekers, the Agency Owner and President at Arthrex, leads strategic initiatives and business development for a key agency within the Arthrex network. Reekers drives market expansion and cultivates strong relationships with healthcare professionals, ensuring the effective distribution and adoption of Arthrex's orthopedic solutions. This leadership role focuses on translating company objectives into actionable strategies that enhance regional market presence and sales performance. Curt Reekers' expertise in agency management is crucial for optimizing sales channels and delivering exceptional service to surgeons and their patients. The Agency Owner and President oversees all aspects of agency operations, from team leadership to financial oversight. Reekers' commitment to innovation and excellence supports Arthrex's mission to improve surgical outcomes.
Chadwick Cooper - Owner and President
Chadwick Cooper, the Owner and President at Arthrex, directs the strategic vision and operational management of a significant segment of the company's business. Cooper is responsible for driving growth, fostering innovation, and ensuring the successful implementation of Arthrex's product portfolio within designated markets. This executive position demands a deep understanding of the orthopedic industry and a commitment to advancing surgical techniques through superior medical devices and education. Chadwick Cooper's leadership focuses on building high-performing teams and cultivating strong partnerships with surgeons and healthcare institutions. The Owner and President plays a pivotal role in shaping market strategies and ensuring operational excellence. Cooper's dedication to quality and advancement underpins Arthrex's reputation for innovation.
Chris Donnelly - President
Chris Donnelly, the President at Arthrex, spearheads strategic growth and market development initiatives across key operational areas. Donnelly directs efforts to expand Arthrex's global reach and enhance its offerings in orthopedic products and medical education. This leadership role involves fostering innovation, optimizing sales strategies, and ensuring the highest standards of product quality and customer support. Chris Donnelly's focus is on driving revenue growth and strengthening Arthrex's position as a leader in the medical device industry. The President collaborates closely with other executives to align departmental objectives with the company's overall mission. Donnelly's strategic oversight is instrumental in advancing surgical techniques and improving patient care worldwide.
Jennifer Ciesinski - Director At Large
Jennifer Ciesinski, the Director At Large at Arthrex, provides broad strategic guidance and oversight across various key business functions. Ciesinski's role involves contributing to high-level decision-making and ensuring alignment with Arthrex's overarching mission of advancing orthopedic surgery through innovative products and education. This position requires a comprehensive understanding of the medical device industry and the ability to identify emerging opportunities and challenges. Jennifer Ciesinski's input is vital for shaping strategic initiatives and fostering a culture of continuous improvement. The Director At Large collaborates with other senior leaders to drive progress in product development, market penetration, and operational effectiveness. Ciesinski's broad perspective supports Arthrex's commitment to surgeon education and patient care.
Explore Leadership Teams in Manufacturing
Siemens Healthineers, founded in 1847 and headquartered in Bavaria, Germany, is a global medical technology company specializing in manufacturing medical equipment and providing healthcare software solutions. The company offers a comprehensive portfolio of products and services in diagnostic imaging, laboratory diagnostics, and advanced therapies to help healthcare providers deliver high-quality patient care. Siemens Healthineers operates across multiple continents with a significant presence in Europe, North America, and Asia, serving hospitals, clinics, and medical facilities worldwide with innovative medical technology solutions.
Company Leadership DK
SZ
WS Audiology, formed in 2019 through the merger of Sivantos and Widex, is a global leader in hearing healthcare technology. The company combines over 140 years of experience in developing innovative solutions for people with hearing loss. WS Audiology offers a diverse portfolio of hearing aid brands including Widex, Signia, Rexton, Audio Service, and Vibe. The company provides comprehensive hearing solutions through multiple channels including wholesale, retail, online platforms, managed care, and diagnostic services. Operating in more than 125 markets worldwide, WS Audiology is privately owned with investment from EQT. The company focuses on creating advanced hearing technology that improves quality of life by making quality sound accessible to individuals with hearing impairments.
Company Leadership DD
WL
TW
SW
MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The companys proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta,...
Company Leadership
WT
DR
DM
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership
CH
Frequently Asked Questions Regarding Arthrex Top Executives and Leadership Team
Unlock more people and company data
